In the present study, we found that the serum FGF23 concentrations of patients with EP are significantly higher than those of healthy individuals matched for age, sex, and a history of hypertension, diabetes, or hyperlipidemia, suggesting that patients with EP may be at higher risk of heart failure than the healthy population. The gene discussed is FGF23; the disease is hyperlipidemia.